JP2007530696A5 - - Google Patents

Download PDF

Info

Publication number
JP2007530696A5
JP2007530696A5 JP2007506409A JP2007506409A JP2007530696A5 JP 2007530696 A5 JP2007530696 A5 JP 2007530696A5 JP 2007506409 A JP2007506409 A JP 2007506409A JP 2007506409 A JP2007506409 A JP 2007506409A JP 2007530696 A5 JP2007530696 A5 JP 2007530696A5
Authority
JP
Japan
Prior art keywords
alkyl
group
hydrogen
cyano
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007506409A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007530696A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/010224 external-priority patent/WO2005097767A1/en
Publication of JP2007530696A publication Critical patent/JP2007530696A/ja
Publication of JP2007530696A5 publication Critical patent/JP2007530696A5/ja
Withdrawn legal-status Critical Current

Links

JP2007506409A 2004-03-30 2005-03-25 アスパラギン酸プロテアーゼ阻害剤として有用な2−アミノチアゾール化合物 Withdrawn JP2007530696A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55776904P 2004-03-30 2004-03-30
US59138604P 2004-07-27 2004-07-27
PCT/US2005/010224 WO2005097767A1 (en) 2004-03-30 2005-03-25 2-aminothiazole compounds useful as aspartyl protease inhibitors

Publications (2)

Publication Number Publication Date
JP2007530696A JP2007530696A (ja) 2007-11-01
JP2007530696A5 true JP2007530696A5 (cg-RX-API-DMAC7.html) 2008-05-08

Family

ID=35124991

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007506409A Withdrawn JP2007530696A (ja) 2004-03-30 2005-03-25 アスパラギン酸プロテアーゼ阻害剤として有用な2−アミノチアゾール化合物

Country Status (6)

Country Link
US (1) US20070203147A1 (cg-RX-API-DMAC7.html)
EP (1) EP1732906A4 (cg-RX-API-DMAC7.html)
JP (1) JP2007530696A (cg-RX-API-DMAC7.html)
AU (1) AU2005230878A1 (cg-RX-API-DMAC7.html)
CA (1) CA2561267A1 (cg-RX-API-DMAC7.html)
WO (1) WO2005097767A1 (cg-RX-API-DMAC7.html)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
US7592348B2 (en) 2003-12-15 2009-09-22 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7700603B2 (en) 2003-12-15 2010-04-20 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7847100B2 (en) 2004-04-20 2010-12-07 Merck, Sharp & Dohme, Inc. 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease
AU2005309760A1 (en) 2004-11-23 2006-06-01 Merck & Co., Inc. 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease
WO2006080406A1 (ja) * 2005-01-28 2006-08-03 Taisho Pharmaceutical Co., Ltd. 三環性化合物
ES2537898T3 (es) 2005-10-25 2015-06-15 Shionogi & Co., Ltd. Derivados de aminotiazolidina y aminotetrahidrotiazepina como inhibidores de BACE 1
TW200815349A (en) 2006-06-22 2008-04-01 Astrazeneca Ab New compounds
ATE543810T1 (de) 2006-09-01 2012-02-15 Merck Sharp & Dohme Hemmer des 5-lipoxygenase aktivierenden proteins (flap)
MX2009006228A (es) 2006-12-12 2009-06-22 Schering Corp Inhibidores de aspartil proteasa.
EP2151435A4 (en) 2007-04-24 2011-09-14 Shionogi & Co PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
AU2008245082B8 (en) 2007-04-24 2012-09-13 Shionogi & Co., Ltd. Aminodihydrothiazine derivatives substituted with a cyclic group
CA2707360A1 (en) * 2007-06-20 2008-12-24 Merck Sharp & Dohme Corp. Diphenyl substituted alkanes
BRPI0906962B8 (pt) 2008-01-18 2021-05-25 Eisai R&D Man Co Ltd composto de aminodiidrotiazina fundido
AU2009217518A1 (en) 2008-02-28 2009-09-03 Merck Sharp & Dohme Corp. 2-aminoimidazole beta-secretase inhibitors for the treatment of Alzheimer's disease
US8637504B2 (en) 2008-06-13 2014-01-28 Shionogi & Co., Ltd. Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
WO2010013302A1 (ja) * 2008-07-28 2010-02-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 スピロアミノジヒドロチアジン誘導体
AU2009277485B2 (en) 2008-07-28 2013-05-02 Eisai R&D Management Co., Ltd. Spiroaminodihydrothiazine derivatives
MX2011002705A (es) 2008-09-11 2011-09-09 Amgen Inc Compuestos con anillos espiro-triciclicos como moduladores de beta-secretasas y metodos de uso.
KR20110076965A (ko) 2008-09-30 2011-07-06 에자이 알앤드디 매니지먼트 가부시키가이샤 신규한 축합 아미노 디하이드로티아진 유도체
WO2010047372A1 (ja) 2008-10-22 2010-04-29 塩野義製薬株式会社 Bace1阻害活性を有する2-アミノピリミジン-4-オンおよび2-アミノピリジン誘導体
TW201020244A (en) 2008-11-14 2010-06-01 Astrazeneca Ab New compounds
US20120015961A1 (en) 2009-03-31 2012-01-19 Shionogi & Co., Ltd. Isothiourea derivatives or isourea derivatives having bace1 inhibitory activity
GB0912778D0 (en) 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydro-oxazine derivatives
GB0912777D0 (en) 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydropyrimidone derivatives
EP2281824A1 (en) 2009-08-07 2011-02-09 Noscira, S.A. Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
US20120245154A1 (en) 2009-12-09 2012-09-27 Shionogi & Co., Ltd. Substituted aminothiazine derivative
RU2012129168A (ru) 2009-12-11 2014-01-20 Сионоги Энд Ко. Лтд. Производные оксазина
MX2012010658A (es) 2010-03-15 2012-12-05 Amgen Inc Compuestos de anillo espiro tetraciclico como moduladores de beta-secretasa.
US8497264B2 (en) 2010-03-15 2013-07-30 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
WO2012019056A1 (en) 2010-08-05 2012-02-09 Amgen Inc. Amino-iso-indole, amino-aza-iso-indole, amino-dihydroisoquinoline and amino-benzoxazine compounds as beta-secretase modulators and methods of use
CA2816285A1 (en) 2010-10-29 2012-05-03 Shionogi & Co., Ltd. Naphthyridine derivative
US9018219B2 (en) 2010-10-29 2015-04-28 Shionogi & Co., Ltd. Fused aminodihydropyrimidine derivative
US9284296B2 (en) 2010-11-22 2016-03-15 Aubergine Pharmaceuticals Llc Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions
WO2012071279A1 (en) 2010-11-23 2012-05-31 Amgen Inc. Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use
GB201100181D0 (en) 2011-01-06 2011-02-23 Eisai Ltd Fused aminodihydrothiazine derivatives
EP2665716B1 (en) 2011-01-21 2017-03-08 Eisai R&D Management Co., Ltd. Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives
GB201101139D0 (en) 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives
GB201101140D0 (en) 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives
US9346827B2 (en) 2011-02-07 2016-05-24 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use
WO2012112462A1 (en) 2011-02-15 2012-08-23 Amgen Inc. Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use
WO2012147763A1 (ja) 2011-04-26 2012-11-01 塩野義製薬株式会社 オキサジン誘導体およびそれを含有するbace1阻害剤
US8957230B2 (en) * 2011-06-30 2015-02-17 Nilesh Shridhar Mulik Synthesis of cleistanthin A and derivatives thereof
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
PH12014500724A1 (en) 2011-10-04 2014-05-19 Institute For Hepatitis And Virus Res Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication
JP2016501827A (ja) 2012-10-24 2016-01-21 塩野義製薬株式会社 Bace1阻害作用を有するジヒドロオキサジンまたはオキサゼピン誘導体
US9725469B2 (en) 2012-11-15 2017-08-08 Amgen, Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用,药物组合物
CN110117263B (zh) * 2019-06-11 2020-12-25 湖南中医药大学 2-氨基-5-酰基噻唑衍生物及其合成方法
US12083099B2 (en) * 2020-10-28 2024-09-10 Accencio LLC Methods of treating symptoms of coronavirus infection with viral protease inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB951885A (en) * 1961-05-13 1964-03-11 Sankyo Co A new process for the preparation of thiazole compounds
JPH07215952A (ja) * 1993-12-06 1995-08-15 Otsuka Pharmaceut Factory Inc カテコール誘導体
JPH1129475A (ja) * 1997-07-07 1999-02-02 Sumitomo Pharmaceut Co Ltd Stat6活性化阻害剤

Similar Documents

Publication Publication Date Title
JP4853284B2 (ja) チアゾール誘導体
JP6506836B2 (ja) B型肝炎ウイルス感染症の処置および予防のための新規ピリダゾンおよびトリアジノン
CN106854205B (zh) 流感病毒复制抑制剂及其使用方法和用途
EP1587585B1 (en) Acylsulfonamide compounds as inhibitors of rna-dependent rna (viral) polymerases
JP2006524222A5 (cg-RX-API-DMAC7.html)
JP2004509066A (ja) 新規抗感染症薬
CN108276401B (zh) 流感病毒复制抑制剂及其用途
JP2003519676A5 (cg-RX-API-DMAC7.html)
JP2002543185A5 (cg-RX-API-DMAC7.html)
JP2006517536A (ja) ウイルスポリメラーゼインヒビター
RU2006132463A (ru) Антагонисты рецептора хемокина
KR20160100329A (ko) 지질 합성의 헤테로사이클릭 조절물질 및 이들의 조합물
CN1984908A (zh) 病毒聚合酶抑制剂
JP2003502367A5 (cg-RX-API-DMAC7.html)
JP2008518969A5 (cg-RX-API-DMAC7.html)
JP2002544187A5 (cg-RX-API-DMAC7.html)
JP2004532240A5 (cg-RX-API-DMAC7.html)
JP2004517130A5 (cg-RX-API-DMAC7.html)
RU2004118423A (ru) Производные бензотиазола в качестве лигандов рецептора аденозина
CN108727369A (zh) 流感病毒复制抑制剂及其用途
JP2005511594A5 (cg-RX-API-DMAC7.html)
JP2008521908A5 (cg-RX-API-DMAC7.html)
JP2007527904A5 (cg-RX-API-DMAC7.html)
CN110446711A (zh) 流感病毒复制抑制剂及其用途
JP2005536531A5 (cg-RX-API-DMAC7.html)